Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
BeyondSpring to reduce U.S. workforce by 35% in streamlining initiative » 16:09
01/11/22
01/11
16:09
01/11/22
16:09
BYSI

BeyondSpring

$4.39 /

+0.14 (+3.29%)

BeyondSpring announced an…

BeyondSpring announced an organizational streamlining initiative focused on prioritizing the Company's highest value business activities, extending its cash runway and preserving long-term sustainability. As part of the reorganization, BeyondSpring is reducing its U.S. workforce by 35%, including reassignment of certain personnel to subsidiaries, which is expected to result in cost savings that will extend the cash runway. The reorganization follows BeyondSpring's receipt of a complete response letter, or CRL, from the FDA for the new drug application, or NDA, seeking approval of plinabulin in combination with granulocyte colony-stimulating factor for the prevention of chemotherapy-induced neutropenia, or CIN, on November 30, 2021."The reorganization of BeyondSpring is a necessary step forward for the Company to deliver on its mission to develop innovative cancer therapies and improve clinical outcomes for patients who have high unmet medical needs globally," said Lan Huang, BeyondSpring's co-founder, chief executive officer and chairwoman. "This reorganization will enable BeyondSpring to reduce operating expenses and extend its cash runway. We express sincere appreciation to colleagues impacted by this decision, and thank our team members for their contributions."

ShowHide Related Items >><<
BYSI BeyondSpring
$4.39 /

+0.14 (+3.29%)

BYSI BeyondSpring
$4.39 /

+0.14 (+3.29%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.39 /

+0.14 (+3.29%)

BYSI BeyondSpring
$4.39 /

+0.14 (+3.29%)

BYSI BeyondSpring
$4.39 /

+0.14 (+3.29%)

Hot Stocks
Vaxxinity appoints Pesile as SVP, Finance & Accounting, Horning to board » 07:20
01/04/22
01/04
07:20
01/04/22
07:20
VAXX

Vaxxinity

$5.90 /

+0.35 (+6.31%)

, BYSI

BeyondSpring

$5.03 /

+0.49 (+10.79%)

, XMTR

Xometry

$54.00 /

+2.92 (+5.72%)

, HWEL

Healthwell Acquisition Corp. I

$9.69 /

+ (+0.00%)

Vaxxinity (VAXX)…

Vaxxinity (VAXX) announced the appointment of Jason Pesile, MBA, CPA, as Senior Vice President, SVP, Finance & Accounting. The Company also announced today the appointment of George Hornig, Chairman of Xometry, to its Board of Directors. Hornig will be the new independent director to chair the Audit Committee, with current Board members Greg Blatt and Peter Diamandis moving to chair the Compensation Committee and Nominating and Governance Committee, respectively. Pesile is a seasoned finance executive with 20 years of experience in the biopharmaceutical space and most recently served as Vice President Finance, Corporate Controller at BeyondSpring Pharmaceuticals (BYSI). Hornig is currently Chairman of Xometry (XMTR), an AI-driven platform for on-demand manufacturing of industrial parts, and Co-Chairman of Healthwell Acquisition (HWEL), a special purpose acquisition company.

ShowHide Related Items >><<
XMTR Xometry
$54.00 /

+2.92 (+5.72%)

BYSI BeyondSpring
$5.03 /

+0.49 (+10.79%)

VAXX Vaxxinity
$5.90 /

+0.35 (+6.31%)

12/29/21 Jefferies
Vaxxinity assumed with a Buy at Jefferies
12/07/21 Jefferies
Vaxxinity initiated with a Buy at Jefferies
12/06/21 BofA
Vaxxinity initiated with a Buy at BofA
12/06/21 BofA
Vaxxinity initiated with a Buy at BofA
BYSI BeyondSpring
$5.03 /

+0.49 (+10.79%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
XMTR Xometry
$54.00 /

+2.92 (+5.72%)

12/09/21 RBC Capital
Xometry price target raised to $58 from $53 at RBC Capital
11/11/21
Fly Intel: Top five analyst upgrades
11/11/21 RBC Capital
Xometry upgraded to Outperform from Sector Perform at RBC Capital
07/26/21 JPMorgan
Xometry initiated with an Overweight at JPMorgan
HWEL Healthwell Acquisition Corp. I
$9.69 /

+ (+0.00%)

XMTR Xometry
$54.00 /

+2.92 (+5.72%)

VAXX Vaxxinity
$5.90 /

+0.35 (+6.31%)

BYSI BeyondSpring
$5.03 /

+0.49 (+10.79%)

  • 11
    Nov
  • 30
    Jun
XMTR Xometry
$54.00 /

+2.92 (+5.72%)

VAXX Vaxxinity
$5.90 /

+0.35 (+6.31%)

HWEL Healthwell Acquisition Corp. I
$9.69 /

+ (+0.00%)

BYSI BeyondSpring
$5.03 /

+0.49 (+10.79%)

XMTR Xometry
$54.00 /

+2.92 (+5.72%)

BYSI BeyondSpring
$5.03 /

+0.49 (+10.79%)

On The Fly
Wall Street in Fives - Must Read Lists for Thursday » 16:31
12/30/21
12/30
16:31
12/30/21
16:31
BIIB

Biogen

$240.10 /

-18.26 (-7.07%)

, TSLA

Tesla

$1,070.41 /

-15.27 (-1.41%)

, KR

Kroger

$45.15 /

+0.44 (+0.98%)

, JNJ

Johnson & Johnson

$172.41 /

+0.85 (+0.50%)

, PFE

Pfizer

$58.42 /

+0.84 (+1.46%)

, BNTX

BioNTech

$256.49 /

+15.94 (+6.63%)

, RCL

Royal Caribbean

$77.31 /

-0.89 (-1.14%)

, CCL

Carnival

$20.53 /

-0.265 (-1.27%)

, NCLH

Norwegian Cruise Line

$21.02 /

-0.555 (-2.57%)

, DIS

Disney

$155.95 /

+1.05 (+0.68%)

, DIDI

Didi

$5.23 /

+0.29 (+5.87%)

, TEVA

Teva

$7.91 /

-0.525 (-6.22%)

, TSCO

Tractor Supply

$236.52 /

-0.38 (-0.16%)

, ZM

Zoom Video

$190.52 /

+8.71 (+4.79%)

, F

Ford

$20.47 /

-0.1 (-0.49%)

, GM

General Motors

$58.14 /

+0.9 (+1.57%)

, LCID

Lucid Group

$38.74 /

+1.805 (+4.89%)

, JBLU

JetBlue

$14.23 /

-0.145 (-1.01%)

, CPNG

Coupang

$29.57 /

+0.61 (+2.11%)

, OTLY

Oatly Group

$8.04 /

+0.15 (+1.90%)

, HOOD

Robinhood

$18.20 /

+1.11 (+6.50%)

, TOST

Toast

$36.75 /

-0.365 (-0.98%)

, RIVN

Rivian Automotive

$103.39 /

+4.12 (+4.15%)

, ET

Energy Transfer LP

$8.16 /

+0.005 (+0.06%)

, WMB

Williams

$25.92 /

-0.12 (-0.46%)

, OCGN

Ocugen

$4.83 /

+0.455 (+10.41%)

, RRD

R.R. Donnelley

$11.27 /

+0.605 (+5.68%)

, CURO

Curo Group

$15.76 /

-0.19 (-1.19%)

, ZEN

Zendesk

$106.09 /

+3.78 (+3.69%)

, MNTV

Momentive

$21.61 /

+0.29 (+1.36%)

, VGR

Vector Group

$11.29 /

-5.88 (-34.25%)

, DOUG

Douglas Elliman

$12.09 /

+1.34 (+12.47%)

, LTTSF

Lotus Ventures

/

+

, BBBY

Bed Bath & Beyond

$14.96 /

+0.045 (+0.30%)

, BYSI

BeyondSpring

$4.64 /

+0.26 (+5.94%)

, AYI

Acuity Brands

$211.60 /

-7.02 (-3.21%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

WMB Williams
$25.92 /

-0.12 (-0.46%)

VGR Vector Group
$11.29 /

-5.88 (-34.25%)

TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

TSCO Tractor Supply
$236.52 /

-0.38 (-0.16%)

TOST Toast
$36.75 /

-0.365 (-0.98%)

TEVA Teva
$7.91 /

-0.525 (-6.22%)

RRD R.R. Donnelley
$11.27 /

+0.605 (+5.68%)

RIVN Rivian Automotive
$103.39 /

+4.12 (+4.15%)

RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

PFE Pfizer
$58.42 /

+0.84 (+1.46%)

OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

MNTV Momentive
$21.61 /

+0.29 (+1.36%)

LTTSF Lotus Ventures
/

+

LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

KR Kroger
$45.15 /

+0.44 (+0.98%)

JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

GM General Motors
$58.14 /

+0.9 (+1.57%)

F Ford
$20.47 /

-0.1 (-0.49%)

ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

DOUG Douglas Elliman
$12.09 /

+1.34 (+12.47%)

DIS Disney
$155.95 /

+1.05 (+0.68%)

DIDI Didi
$5.23 /

+0.29 (+5.87%)

CURO Curo Group
$15.76 /

-0.19 (-1.19%)

CPNG Coupang
$29.57 /

+0.61 (+2.11%)

CCL Carnival
$20.53 /

-0.265 (-1.27%)

BYSI BeyondSpring
$4.64 /

+0.26 (+5.94%)

BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

AYI Acuity Brands
$211.60 /

-7.02 (-3.21%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

12/30/21 Oppenheimer
Biogen 'appears to be in play' after takeover talks report, says Oppenheimer
12/30/21 Cantor Fitzgerald
Biogen takeout would be 'best-case exit strategy', says Cantor Fitzgerald
12/30/21 Baird
Biogen buyout rumor seems 'odd from multiple perspectives,' says Baird
12/30/21 Canaccord
Biogen takeout report may bring 'downside protection,' says Canaccord
TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

12/30/21 Citi
Tesla price target raised to $262 from $236 at Citi
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
12/28/21 Argus
Tesla price target raised to $1,313 from $1,010 at Argus
12/28/21 Wedbush
Tesla in 'clear position of strength' heading into 2022, says Wedbush
KR Kroger
$45.15 /

+0.44 (+0.98%)

12/03/21 MKM Partners
Kroger price target raised to $48 from $44 at MKM Partners
12/03/21 Credit Suisse
Kroger price target raised to $47 from $40 at Credit Suisse
12/03/21 BMO Capital
Kroger price target raised to $41 from $39 at BMO Capital
12/03/21 Deutsche Bank
Kroger price target raised to $45 from $43 at Deutsche Bank
JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

12/29/21 Credit Suisse
Credit Suisse reiterates Outperform on J&J as trends point to pharma upside
12/17/21
Fly Intel: Top five analyst initiations
12/17/21 Goldman Sachs
Goldman starts Johnson & Johnson at Neutral amid disruption risk
12/17/21 Goldman Sachs
Johnson & Johnson initiated with a Neutral at Goldman Sachs
PFE Pfizer
$58.42 /

+0.84 (+1.46%)

12/30/21 KeyBanc
Pfizer deal provides key validation of Codex DNA's technology, says KeyBanc
12/27/21 Stifel
BridgeBio trial failure positive for Alnylam, says Stifel
12/23/21 Mizuho
Mizuho sees market for both Merck's molnupiravir, Pfizer's Paxlovid
12/22/21 Craig-Hallum
Craig-Hallum bullish on Codexis, sees potential for upside to 2022 estimates
BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

12/22/21 Kempen
BioNTech upgraded to Buy from Neutral at Kempen
12/21/21 H.C. Wainwright
BioNTech price target raised to $366 from $360 at H.C. Wainwright
12/16/21 Morgan Stanley
BioNTech initiated with an Equal Weight at Morgan Stanley
12/06/21 BofA
BioNTech price target raised to $349 from $341 at BofA
RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

12/10/21
Fly Intel: Top five analyst upgrades
12/10/21 Berenberg
Royal Caribbean upgraded to Hold from Sell at Berenberg
11/01/21 Deutsche Bank
Royal Caribbean price target lowered to $81 from $83 at Deutsche Bank
09/24/21 Stifel
Royal Caribbean price target raised to $111 from $95 at Stifel
CCL Carnival
$20.53 /

-0.265 (-1.27%)

12/21/21 Goldman Sachs
Carnival price target lowered to $21 from $24 at Goldman Sachs
10/25/21
Fly Intel: Top five analyst downgrades
10/25/21 Citi
Citi downgrades Carnival to Neutral, sees more upside in Norwegian
10/25/21 Citi
Carnival downgraded to Neutral from Buy at Citi
NCLH Norwegian Cruise Line
$21.02 /

-0.555 (-2.57%)

11/16/21 Stifel
Norwegian Cruise Line weakness a buying opportunity, says Stifel
11/11/21 Berenberg
Norwegian Cruise Line price target raised to $27 from $25 at Berenberg
11/05/21 Deutsche Bank
Norwegian Cruise Line price target raised to $28 from $26 at Deutsche Bank
DIS Disney
$155.95 /

+1.05 (+0.68%)

12/14/21 Morgan Stanley
Disney price target lowered to $185 from $210 at Morgan Stanley
12/14/21 Macquarie
Disney price target lowered to $185 from $195 at Macquarie
12/13/21 KeyBanc
KeyBanc bullish on Disney, says 'significantly undervalued'
12/09/21 BofA
Rexford Industrial added to US 1 List; Duke Realty & Disney removed at BofA
DIDI Didi
$5.23 /

+0.29 (+5.87%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
TEVA Teva
$7.91 /

-0.525 (-6.22%)

10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
10/28/21 Raymond James
Teva downgraded to Market Perform from Outperform at Raymond James
06/22/21 JPMorgan
Opioid settlement would be best case for manufacturers, says JPMorgan
05/04/21 UBS
Teva downgraded to Neutral from Buy at UBS
TSCO Tractor Supply
$236.52 /

-0.38 (-0.16%)

12/30/21 Argus
Tractor Supply upgraded to Buy from Hold at Argus
12/30/21 DA Davidson
Tractor Supply price target raised to $232 from $216 at DA Davidson
11/11/21 Gordon Haskett
Tractor Supply upgraded to Buy from Accumulate at Gordon Haskett
10/22/21 Loop Capital
Tractor Supply price target raised to $215 from $200 at Loop Capital
ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

12/30/21
Citic starts Zoom Video with Buy on 'clearly excessive' concerns
12/30/21
Zoom Video initiated with a Buy at Citic Securities
12/16/21
Fly Intel: Top five analyst initiations
12/16/21 Goldman Sachs
Zoom Video initiated with a Neutral at Goldman Sachs
F Ford
$20.47 /

-0.1 (-0.49%)

12/30/21 Citi
Ford price target raised to $23 from $20 at Citi
12/16/21 Wells Fargo
Ford price target raised to $25 from $19 at Wells Fargo
12/16/21 Barclays
Ford price target raised to $23 from $18 at Barclays
GM General Motors
$58.14 /

+0.9 (+1.57%)

12/30/21 Citi
General Motors price target raised to $96 from $90 at Citi
12/16/21 Wells Fargo
General Motors price target raised to $74 from $67 at Wells Fargo
LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

12/30/21 Citi
Lucid Group resumed with a Buy at Citi
12/20/21
Fly Intel: Top five analyst initiations
12/20/21 Guggenheim
Guggenheim starts Lucid Group at Neutral, sees fair value at $38 per share
12/20/21 Guggenheim
Lucid Group initiated with a Neutral at Guggenheim
JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Exane BNP Paribas
JetBlue upgraded to Neutral from Underperform at Exane BNP Paribas
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/06/21
Fly Intel: Top five analyst downgrades
CPNG Coupang
$29.57 /

+0.61 (+2.11%)

11/15/21 Mizuho
Coupang price target lowered to $32 from $40 at Mizuho
10/12/21 Citi
Coupang price target lowered to $32 from $39 at Citi
08/26/21 Daiwa
Coupang upgraded to Buy on improving fundamentals at Daiwa
08/26/21 Daiwa
Coupang upgraded to Buy from Outperform at Daiwa
OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

12/03/21 Piper Sandler
Beyond Meat price target lowered to $61 from $72 at Piper Sandler
11/30/21 HSBC
HSBC starts Oatly at sell, says management overestimated market
11/30/21 HSBC
Oatly Group initiated with a Reduce at HSBC
11/22/21
Fly Intel: Top five analyst downgrades
HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

12/17/21 Deutsche Bank
Robinhood price target lowered to $17 from $32 at Deutsche Bank
12/16/21 JPMorgan
Robinhood price target lowered to $17 from $26 at JPMorgan
12/15/21 BofA
BofA starts Robinhood at Underperform, says 'perfect storm is over'
12/15/21 BofA
Robinhood initiated with an Underperform at BofA
TOST Toast
$36.75 /

-0.365 (-0.98%)

12/16/21 Morgan Stanley
Toast upgraded to Overweight after significant pullback at Morgan Stanley
12/16/21 Morgan Stanley
Toast upgraded to Overweight from Equal Weight at Morgan Stanley
12/10/21 Northcoast
Toast initiated with a Neutral at Northcoast
11/10/21 Canaccord
Toast price target raised to $64 from $60 at Canaccord
RIVN Rivian Automotive
$103.39 /

+4.12 (+4.15%)

12/17/21 Barclays
Rivian Automotive price target lowered to $115 from $120 at Barclays
12/17/21 Piper Sandler
Piper surprised by Rivian selloff, says production numbers 'meaningless'
12/10/21 Tigress Financial
Rivian Automotive initiated with a Buy at Tigress Financial
ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

12/07/21 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Energy Transfer LP reinstated with a Buy at BofA
09/21/21 Tudor Pickering
Energy Transfer LP upgraded to Buy from Hold at Tudor Pickering
WMB Williams
$25.92 /

-0.12 (-0.46%)

12/17/21
Fly Intel: Top five analyst downgrades
12/17/21 Citi
Williams downgraded to Neutral from Buy at Citi
11/18/21 US Capital Advisors
Williams downgraded to Hold from Overweight at US Capital Advisors
10/19/21
Fly Intel: Top five analyst downgrades
OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

07/26/21 Noble Capital
Ocugen initiated with an Outperform at Noble Capital
07/06/21 Roth Capital
Covaxin data continue to meet FDA efficacy threshold, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
RRD R.R. Donnelley
$11.27 /

+0.605 (+5.68%)

CURO Curo Group
$15.76 /

-0.19 (-1.19%)

12/30/21 Credit Suisse
Curo Group price target lowered to $26 from $29 at Credit Suisse
12/30/21 Jefferies
Curo Group resumed with a Buy at Jefferies
09/28/21 Janney Montgomery Scott
Janney raises Curo Group fair value estimate to $25 after guidance
ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

11/30/21 Craig-Hallum
Zendesk price target lowered to $140 from $150 at Craig-Hallum
11/19/21
Fly Intel: Top five analyst downgrades
11/19/21 Stifel
Zendesk's upcoming deal proxy may help investors gain comfort, says Stifel
11/19/21 Cowen
Zendesk downgraded to Market Perform from Outperform at Cowen
MNTV Momentive
$21.61 /

+0.29 (+1.36%)

11/18/21 Jefferies
Zendesk price target lowered to $110 from $120 at Jefferies
11/16/21 Credit Suisse
Zendesk initiated with a Neutral at Credit Suisse
VGR Vector Group
$11.29 /

-5.88 (-34.25%)

11/15/21 Barclays
Vector Group upgraded to Equal Weight from Underweight at Barclays
11/09/21 Oppenheimer
Vector Group upgraded to Outperform from Perform at Oppenheimer
09/13/21 Barclays
Vector Group downgraded to Underweight from Equal Weight at Barclays
DOUG Douglas Elliman
$12.09 /

+1.34 (+12.47%)

LTTSF Lotus Ventures
/

+

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

11/03/21
Fly Intel: Top five analyst downgrades
11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
11/03/21 Loop Capital
Bed Bath & Beyond downgraded to Sell from Hold at Loop Capital
10/14/21 Morgan Stanley
Morgan Stanley downgrades Bed Bath & Beyond to sell ahead of category declines
BYSI BeyondSpring
$4.64 /

+0.26 (+5.94%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
AYI Acuity Brands
$211.60 /

-7.02 (-3.21%)

10/12/21 UBS
Acuity Brands upgraded to Neutral from Sell at UBS
10/07/21 Wells Fargo
Acuity Brands initiated with an Overweight at Wells Fargo
10/07/21 Wells Fargo
Acuity Brands initiated with an Overweight at Wells Fargo
10/07/21 Cowen
Acuity Brands price target raised to $223 from $184 at Cowen
ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

WMB Williams
$25.92 /

-0.12 (-0.46%)

VGR Vector Group
$11.29 /

-5.88 (-34.25%)

TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

TSCO Tractor Supply
$236.52 /

-0.38 (-0.16%)

TOST Toast
$36.75 /

-0.365 (-0.98%)

TEVA Teva
$7.91 /

-0.525 (-6.22%)

RRD R.R. Donnelley
$11.27 /

+0.605 (+5.68%)

RIVN Rivian Automotive
$103.39 /

+4.12 (+4.15%)

RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

PFE Pfizer
$58.42 /

+0.84 (+1.46%)

OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

NCLH Norwegian Cruise Line
$21.02 /

-0.555 (-2.57%)

MNTV Momentive
$21.61 /

+0.29 (+1.36%)

LTTSF Lotus Ventures
/

+

LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

KR Kroger
$45.15 /

+0.44 (+0.98%)

JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

GM General Motors
$58.14 /

+0.9 (+1.57%)

F Ford
$20.47 /

-0.1 (-0.49%)

ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

DIS Disney
$155.95 /

+1.05 (+0.68%)

DIDI Didi
$5.23 /

+0.29 (+5.87%)

CURO Curo Group
$15.76 /

-0.19 (-1.19%)

CPNG Coupang
$29.57 /

+0.61 (+2.11%)

CCL Carnival
$20.53 /

-0.265 (-1.27%)

BYSI BeyondSpring
$4.64 /

+0.26 (+5.94%)

BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

AYI Acuity Brands
$211.60 /

-7.02 (-3.21%)

  • 08
    Dec
  • 10
    Nov
  • 14
    Sep
  • 22
    Sep
  • 29
    Jul
  • 30
    Jun
  • 20
    May
  • 05
    Mar
  • 11
    Mar
  • 01
    Mar
  • 23
    Feb
  • 13
    Jan
ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

TEVA Teva
$7.91 /

-0.525 (-6.22%)

RRD R.R. Donnelley
$11.27 /

+0.605 (+5.68%)

RIVN Rivian Automotive
$103.39 /

+4.12 (+4.15%)

RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

PFE Pfizer
$58.42 /

+0.84 (+1.46%)

OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

NCLH Norwegian Cruise Line
$21.02 /

-0.555 (-2.57%)

LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

KR Kroger
$45.15 /

+0.44 (+0.98%)

JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

GM General Motors
$58.14 /

+0.9 (+1.57%)

F Ford
$20.47 /

-0.1 (-0.49%)

ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

DIS Disney
$155.95 /

+1.05 (+0.68%)

DIDI Didi
$5.23 /

+0.29 (+5.87%)

CPNG Coupang
$29.57 /

+0.61 (+2.11%)

CCL Carnival
$20.53 /

-0.265 (-1.27%)

BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

WMB Williams
$25.92 /

-0.12 (-0.46%)

VGR Vector Group
$11.29 /

-5.88 (-34.25%)

TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

TSCO Tractor Supply
$236.52 /

-0.38 (-0.16%)

TOST Toast
$36.75 /

-0.365 (-0.98%)

TEVA Teva
$7.91 /

-0.525 (-6.22%)

RRD R.R. Donnelley
$11.27 /

+0.605 (+5.68%)

RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

PFE Pfizer
$58.42 /

+0.84 (+1.46%)

OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

MNTV Momentive
$21.61 /

+0.29 (+1.36%)

LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

KR Kroger
$45.15 /

+0.44 (+0.98%)

JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

F Ford
$20.47 /

-0.1 (-0.49%)

ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

DIS Disney
$155.95 /

+1.05 (+0.68%)

DIDI Didi
$5.23 /

+0.29 (+5.87%)

CURO Curo Group
$15.76 /

-0.19 (-1.19%)

CPNG Coupang
$29.57 /

+0.61 (+2.11%)

CCL Carnival
$20.53 /

-0.265 (-1.27%)

BYSI BeyondSpring
$4.64 /

+0.26 (+5.94%)

BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

AYI Acuity Brands
$211.60 /

-7.02 (-3.21%)

ZM Zoom Video
$190.52 /

+8.71 (+4.79%)

ZEN Zendesk
$106.09 /

+3.78 (+3.69%)

WMB Williams
$25.92 /

-0.12 (-0.46%)

VGR Vector Group
$11.29 /

-5.88 (-34.25%)

TSLA Tesla
$1,070.41 /

-15.27 (-1.41%)

TSCO Tractor Supply
$236.52 /

-0.38 (-0.16%)

TOST Toast
$36.75 /

-0.365 (-0.98%)

TEVA Teva
$7.91 /

-0.525 (-6.22%)

RIVN Rivian Automotive
$103.39 /

+4.12 (+4.15%)

RCL Royal Caribbean
$77.31 /

-0.89 (-1.14%)

PFE Pfizer
$58.42 /

+0.84 (+1.46%)

OTLY Oatly Group
$8.04 /

+0.15 (+1.90%)

OCGN Ocugen
$4.83 /

+0.455 (+10.41%)

NCLH Norwegian Cruise Line
$21.02 /

-0.555 (-2.57%)

LCID Lucid Group
$38.74 /

+1.805 (+4.89%)

KR Kroger
$45.15 /

+0.44 (+0.98%)

JNJ Johnson & Johnson
$172.41 /

+0.85 (+0.50%)

JBLU JetBlue
$14.23 /

-0.145 (-1.01%)

HOOD Robinhood
$18.20 /

+1.11 (+6.50%)

GM General Motors
$58.14 /

+0.9 (+1.57%)

F Ford
$20.47 /

-0.1 (-0.49%)

ET Energy Transfer LP
$8.16 /

+0.005 (+0.06%)

DIS Disney
$155.95 /

+1.05 (+0.68%)

DIDI Didi
$5.23 /

+0.29 (+5.87%)

CPNG Coupang
$29.57 /

+0.61 (+2.11%)

CCL Carnival
$20.53 /

-0.265 (-1.27%)

BYSI BeyondSpring
$4.64 /

+0.26 (+5.94%)

BNTX BioNTech
$256.49 /

+15.94 (+6.63%)

BIIB Biogen
$240.10 /

-18.26 (-7.07%)

BBBY Bed Bath & Beyond
$14.96 /

+0.045 (+0.30%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:20
12/30/21
12/30
12:20
12/30/21
12:20
BIIB

Biogen

$237.29 /

-21.07 (-8.16%)

, TSLA

Tesla

$1,091.10 /

+5.42 (+0.50%)

, KR

Kroger

$44.86 /

+0.15 (+0.34%)

, RCL

Royal Caribbean

$79.39 /

+1.19 (+1.52%)

, JNJ

Johnson & Johnson

$172.23 /

+0.67 (+0.39%)

, DIDI

Didi

$5.26 /

+0.32 (+6.48%)

, TSCO

Tractor Supply

$237.00 /

+0.1 (+0.04%)

, ZM

Zoom Video

$190.10 /

+8.29 (+4.56%)

, F

Ford

$20.74 /

+0.165 (+0.80%)

, GM

General Motors

$58.71 /

+1.47 (+2.57%)

, LCID

Lucid Group

$39.19 /

+2.255 (+6.11%)

, JBLU

JetBlue

$14.44 /

+0.065 (+0.45%)

, CPNG

Coupang

$29.86 /

+0.895 (+3.09%)

, OTLY

Oatly Group

$8.16 /

+0.27 (+3.42%)

, HOOD

Robinhood

$18.24 /

+1.145 (+6.70%)

, TOST

Toast

$37.50 /

+0.39 (+1.05%)

, RIVN

Rivian Automotive

$104.33 /

+5.06 (+5.10%)

, CS

Credit Suisse

$9.68 /

+0.04 (+0.41%)

, ZEN

Zendesk

$105.07 /

+2.76 (+2.70%)

, MNTV

Momentive

$21.73 /

+0.41 (+1.92%)

, ET

Energy Transfer LP

$8.23 /

+0.075 (+0.92%)

, WMB

Williams

$26.03 /

-0.01 (-0.04%)

, OCGN

Ocugen

$4.92 /

+0.55 (+12.59%)

, RRD

R.R. Donnelley

$11.19 /

+0.53 (+4.97%)

, CURO

Curo Group

$15.73 /

-0.22 (-1.38%)

, MU

Micron

$95.23 /

-0.93 (-0.97%)

, VGR

Vector Group

$11.20 /

-5.97 (-34.77%)

, DOUG

Douglas Elliman

$10.65 /

-0.21 (-1.93%)

, LTTSF

Lotus Ventures

/

+

, BBBY

Bed Bath & Beyond

$15.27 /

+0.36 (+2.41%)

, BYSI

BeyondSpring

$4.46 /

+0.08 (+1.83%)

, AYI

Acuity Brands

$214.52 /

-4.1 (-1.88%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

WMB Williams
$26.03 /

-0.01 (-0.04%)

VGR Vector Group
$11.20 /

-5.97 (-34.77%)

TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

TSCO Tractor Supply
$237.00 /

+0.1 (+0.04%)

TOST Toast
$37.50 /

+0.39 (+1.05%)

RRD R.R. Donnelley
$11.19 /

+0.53 (+4.97%)

RIVN Rivian Automotive
$104.33 /

+5.06 (+5.10%)

RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

MU Micron
$95.23 /

-0.93 (-0.97%)

MNTV Momentive
$21.73 /

+0.41 (+1.92%)

LTTSF Lotus Ventures
/

+

LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

KR Kroger
$44.86 /

+0.15 (+0.34%)

JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

GM General Motors
$58.71 /

+1.47 (+2.57%)

F Ford
$20.74 /

+0.165 (+0.80%)

ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

DOUG Douglas Elliman
$10.65 /

-0.21 (-1.93%)

DIDI Didi
$5.26 /

+0.32 (+6.48%)

CURO Curo Group
$15.73 /

-0.22 (-1.38%)

CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

CPNG Coupang
$29.86 /

+0.895 (+3.09%)

BYSI BeyondSpring
$4.46 /

+0.08 (+1.83%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

AYI Acuity Brands
$214.52 /

-4.1 (-1.88%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

12/30/21 Oppenheimer
Biogen 'appears to be in play' after takeover talks report, says Oppenheimer
12/30/21 Cantor Fitzgerald
Biogen takeout would be 'best-case exit strategy', says Cantor Fitzgerald
12/30/21 Baird
Biogen buyout rumor seems 'odd from multiple perspectives,' says Baird
12/30/21 Canaccord
Biogen takeout report may bring 'downside protection,' says Canaccord
TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

12/30/21 Citi
Tesla price target raised to $262 from $236 at Citi
12/28/21 BofA
BofA sees December U.S. light vehicle sales down 20%
12/28/21 Argus
Tesla price target raised to $1,313 from $1,010 at Argus
12/28/21 Wedbush
Tesla in 'clear position of strength' heading into 2022, says Wedbush
KR Kroger
$44.86 /

+0.15 (+0.34%)

12/03/21 MKM Partners
Kroger price target raised to $48 from $44 at MKM Partners
12/03/21 Credit Suisse
Kroger price target raised to $47 from $40 at Credit Suisse
12/03/21 BMO Capital
Kroger price target raised to $41 from $39 at BMO Capital
12/03/21 Deutsche Bank
Kroger price target raised to $45 from $43 at Deutsche Bank
RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

12/10/21
Fly Intel: Top five analyst upgrades
12/10/21 Berenberg
Royal Caribbean upgraded to Hold from Sell at Berenberg
11/01/21 Deutsche Bank
Royal Caribbean price target lowered to $81 from $83 at Deutsche Bank
09/24/21 Stifel
Royal Caribbean price target raised to $111 from $95 at Stifel
JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

12/29/21 Credit Suisse
Credit Suisse reiterates Outperform on J&J as trends point to pharma upside
12/17/21
Fly Intel: Top five analyst initiations
12/17/21 Goldman Sachs
Goldman starts Johnson & Johnson at Neutral amid disruption risk
12/17/21 Goldman Sachs
Johnson & Johnson initiated with a Neutral at Goldman Sachs
DIDI Didi
$5.26 /

+0.32 (+6.48%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
TSCO Tractor Supply
$237.00 /

+0.1 (+0.04%)

12/30/21 Argus
Tractor Supply upgraded to Buy from Hold at Argus
12/30/21 DA Davidson
Tractor Supply price target raised to $232 from $216 at DA Davidson
11/11/21 Gordon Haskett
Tractor Supply upgraded to Buy from Accumulate at Gordon Haskett
10/22/21 Loop Capital
Tractor Supply price target raised to $215 from $200 at Loop Capital
ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

12/30/21
Citic starts Zoom Video with Buy on 'clearly excessive' concerns
12/30/21
Zoom Video initiated with a Buy at Citic Securities
12/16/21
Fly Intel: Top five analyst initiations
12/16/21 Goldman Sachs
Zoom Video initiated with a Neutral at Goldman Sachs
F Ford
$20.74 /

+0.165 (+0.80%)

12/30/21 Citi
Ford price target raised to $23 from $20 at Citi
12/16/21 Wells Fargo
Ford price target raised to $25 from $19 at Wells Fargo
12/16/21 Barclays
Ford price target raised to $23 from $18 at Barclays
GM General Motors
$58.71 /

+1.47 (+2.57%)

12/30/21 Citi
General Motors price target raised to $96 from $90 at Citi
12/16/21 Wells Fargo
General Motors price target raised to $74 from $67 at Wells Fargo
LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

12/30/21 Citi
Lucid Group resumed with a Buy at Citi
12/20/21
Fly Intel: Top five analyst initiations
12/20/21 Guggenheim
Guggenheim starts Lucid Group at Neutral, sees fair value at $38 per share
12/20/21 Guggenheim
Lucid Group initiated with a Neutral at Guggenheim
JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

11/17/21
Fly Intel: Top five analyst upgrades
11/17/21 Exane BNP Paribas
JetBlue upgraded to Neutral from Underperform at Exane BNP Paribas
10/12/21 Susquehanna
Susquehanna sees constructive backdrop for air travel in 2022
10/06/21
Fly Intel: Top five analyst downgrades
CPNG Coupang
$29.86 /

+0.895 (+3.09%)

11/15/21 Mizuho
Coupang price target lowered to $32 from $40 at Mizuho
10/12/21 Citi
Coupang price target lowered to $32 from $39 at Citi
08/26/21 Daiwa
Coupang upgraded to Buy on improving fundamentals at Daiwa
08/26/21 Daiwa
Coupang upgraded to Buy from Outperform at Daiwa
OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

12/03/21 Piper Sandler
Beyond Meat price target lowered to $61 from $72 at Piper Sandler
11/30/21 HSBC
HSBC starts Oatly at sell, says management overestimated market
11/30/21 HSBC
Oatly Group initiated with a Reduce at HSBC
11/22/21
Fly Intel: Top five analyst downgrades
HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

12/17/21 Deutsche Bank
Robinhood price target lowered to $17 from $32 at Deutsche Bank
12/16/21 JPMorgan
Robinhood price target lowered to $17 from $26 at JPMorgan
12/15/21 BofA
BofA starts Robinhood at Underperform, says 'perfect storm is over'
12/15/21 BofA
Robinhood initiated with an Underperform at BofA
TOST Toast
$37.50 /

+0.39 (+1.05%)

12/16/21 Morgan Stanley
Toast upgraded to Overweight after significant pullback at Morgan Stanley
12/16/21 Morgan Stanley
Toast upgraded to Overweight from Equal Weight at Morgan Stanley
12/10/21 Northcoast
Toast initiated with a Neutral at Northcoast
11/10/21 Canaccord
Toast price target raised to $64 from $60 at Canaccord
RIVN Rivian Automotive
$104.33 /

+5.06 (+5.10%)

12/17/21 Barclays
Rivian Automotive price target lowered to $115 from $120 at Barclays
12/17/21 Piper Sandler
Piper surprised by Rivian selloff, says production numbers 'meaningless'
12/10/21 Tigress Financial
Rivian Automotive initiated with a Buy at Tigress Financial
CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

12/06/21 UBS
Credit Suisse downgraded to Neutral from Buy at UBS
11/16/21 JPMorgan
Credit Suisse downgraded to Underweight on new strategy at JPMorgan
11/16/21 JPMorgan
Credit Suisse downgraded to Underweight from Neutral at JPMorgan
11/15/21 Morgan Stanley
Credit Suisse price target raised to CHF 12 from CHF 11 at Morgan Stanley
ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

11/30/21 Craig-Hallum
Zendesk price target lowered to $140 from $150 at Craig-Hallum
11/19/21
Fly Intel: Top five analyst downgrades
11/19/21 Stifel
Zendesk's upcoming deal proxy may help investors gain comfort, says Stifel
11/19/21 Cowen
Zendesk downgraded to Market Perform from Outperform at Cowen
MNTV Momentive
$21.73 /

+0.41 (+1.92%)

11/18/21 Jefferies
Zendesk price target lowered to $110 from $120 at Jefferies
11/16/21 Credit Suisse
Zendesk initiated with a Neutral at Credit Suisse
ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

12/07/21 Mizuho
OGE Energy downgraded to Neutral on valuation at Mizuho
09/28/21 BofA
BofA reinstates coverage of U.S. Midstream sector with six buys, four sells
09/28/21 BofA
Energy Transfer LP reinstated with a Buy at BofA
09/21/21 Tudor Pickering
Energy Transfer LP upgraded to Buy from Hold at Tudor Pickering
WMB Williams
$26.03 /

-0.01 (-0.04%)

12/17/21
Fly Intel: Top five analyst downgrades
12/17/21 Citi
Williams downgraded to Neutral from Buy at Citi
11/18/21 US Capital Advisors
Williams downgraded to Hold from Overweight at US Capital Advisors
10/19/21
Fly Intel: Top five analyst downgrades
OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

07/26/21 Noble Capital
Ocugen initiated with an Outperform at Noble Capital
07/06/21 Roth Capital
Covaxin data continue to meet FDA efficacy threshold, says Roth Capital
06/11/21
Fly Intel: Top five analyst downgrades
06/11/21 H.C. Wainwright
Ocugen price target lowered to $10 from $12 at H.C. Wainwright
RRD R.R. Donnelley
$11.19 /

+0.53 (+4.97%)

CURO Curo Group
$15.73 /

-0.22 (-1.38%)

12/30/21 Credit Suisse
Curo Group price target lowered to $26 from $29 at Credit Suisse
12/30/21 Jefferies
Curo Group resumed with a Buy at Jefferies
09/28/21 Janney Montgomery Scott
Janney raises Curo Group fair value estimate to $25 after guidance
MU Micron
$95.23 /

-0.93 (-0.97%)

12/30/21 Lynx
Lynx expects further upside for Micron, notes DRAM prices moving up
12/29/21 Benchmark
Benchmark says Western Digital getting boost from report of Samsung NAND trouble
12/29/21 Wells Fargo
Samsung NAND news positive for Western Digital and Micron, says Wells Fargo
12/21/21
Fly Intel: Top five analyst upgrades
VGR Vector Group
$11.20 /

-5.97 (-34.77%)

11/15/21 Barclays
Vector Group upgraded to Equal Weight from Underweight at Barclays
11/09/21 Oppenheimer
Vector Group upgraded to Outperform from Perform at Oppenheimer
09/13/21 Barclays
Vector Group downgraded to Underweight from Equal Weight at Barclays
DOUG Douglas Elliman
$10.65 /

-0.21 (-1.93%)

LTTSF Lotus Ventures
/

+

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

11/03/21
Fly Intel: Top five analyst downgrades
11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
11/03/21 Loop Capital
Bed Bath & Beyond downgraded to Sell from Hold at Loop Capital
10/14/21 Morgan Stanley
Morgan Stanley downgrades Bed Bath & Beyond to sell ahead of category declines
BYSI BeyondSpring
$4.46 /

+0.08 (+1.83%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
AYI Acuity Brands
$214.52 /

-4.1 (-1.88%)

10/12/21 UBS
Acuity Brands upgraded to Neutral from Sell at UBS
10/07/21 Wells Fargo
Acuity Brands initiated with an Overweight at Wells Fargo
10/07/21 Wells Fargo
Acuity Brands initiated with an Overweight at Wells Fargo
10/07/21 Cowen
Acuity Brands price target raised to $223 from $184 at Cowen
ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

WMB Williams
$26.03 /

-0.01 (-0.04%)

VGR Vector Group
$11.20 /

-5.97 (-34.77%)

TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

TSCO Tractor Supply
$237.00 /

+0.1 (+0.04%)

TOST Toast
$37.50 /

+0.39 (+1.05%)

RRD R.R. Donnelley
$11.19 /

+0.53 (+4.97%)

RIVN Rivian Automotive
$104.33 /

+5.06 (+5.10%)

RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

MU Micron
$95.23 /

-0.93 (-0.97%)

MNTV Momentive
$21.73 /

+0.41 (+1.92%)

LTTSF Lotus Ventures
/

+

LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

KR Kroger
$44.86 /

+0.15 (+0.34%)

JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

GM General Motors
$58.71 /

+1.47 (+2.57%)

F Ford
$20.74 /

+0.165 (+0.80%)

ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

DIDI Didi
$5.26 /

+0.32 (+6.48%)

CURO Curo Group
$15.73 /

-0.22 (-1.38%)

CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

CPNG Coupang
$29.86 /

+0.895 (+3.09%)

BYSI BeyondSpring
$4.46 /

+0.08 (+1.83%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

AYI Acuity Brands
$214.52 /

-4.1 (-1.88%)

  • 08
    Dec
  • 10
    Nov
  • 14
    Sep
  • 22
    Sep
  • 29
    Jul
  • 30
    Jun
  • 20
    May
  • 11
    Mar
  • 01
    Mar
  • 13
    Jan
ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

RRD R.R. Donnelley
$11.19 /

+0.53 (+4.97%)

RIVN Rivian Automotive
$104.33 /

+5.06 (+5.10%)

RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

MU Micron
$95.23 /

-0.93 (-0.97%)

LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

KR Kroger
$44.86 /

+0.15 (+0.34%)

JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

GM General Motors
$58.71 /

+1.47 (+2.57%)

F Ford
$20.74 /

+0.165 (+0.80%)

ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

DIDI Didi
$5.26 /

+0.32 (+6.48%)

CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

CPNG Coupang
$29.86 /

+0.895 (+3.09%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

WMB Williams
$26.03 /

-0.01 (-0.04%)

VGR Vector Group
$11.20 /

-5.97 (-34.77%)

TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

TSCO Tractor Supply
$237.00 /

+0.1 (+0.04%)

TOST Toast
$37.50 /

+0.39 (+1.05%)

RRD R.R. Donnelley
$11.19 /

+0.53 (+4.97%)

RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

MU Micron
$95.23 /

-0.93 (-0.97%)

MNTV Momentive
$21.73 /

+0.41 (+1.92%)

LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

KR Kroger
$44.86 /

+0.15 (+0.34%)

JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

F Ford
$20.74 /

+0.165 (+0.80%)

ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

DIDI Didi
$5.26 /

+0.32 (+6.48%)

CURO Curo Group
$15.73 /

-0.22 (-1.38%)

CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

CPNG Coupang
$29.86 /

+0.895 (+3.09%)

BYSI BeyondSpring
$4.46 /

+0.08 (+1.83%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

AYI Acuity Brands
$214.52 /

-4.1 (-1.88%)

ZM Zoom Video
$190.10 /

+8.29 (+4.56%)

ZEN Zendesk
$105.07 /

+2.76 (+2.70%)

WMB Williams
$26.03 /

-0.01 (-0.04%)

VGR Vector Group
$11.20 /

-5.97 (-34.77%)

TSLA Tesla
$1,091.10 /

+5.42 (+0.50%)

TSCO Tractor Supply
$237.00 /

+0.1 (+0.04%)

TOST Toast
$37.50 /

+0.39 (+1.05%)

RIVN Rivian Automotive
$104.33 /

+5.06 (+5.10%)

RCL Royal Caribbean
$79.39 /

+1.19 (+1.52%)

OTLY Oatly Group
$8.16 /

+0.27 (+3.42%)

OCGN Ocugen
$4.92 /

+0.55 (+12.59%)

MU Micron
$95.23 /

-0.93 (-0.97%)

LCID Lucid Group
$39.19 /

+2.255 (+6.11%)

KR Kroger
$44.86 /

+0.15 (+0.34%)

JNJ Johnson & Johnson
$172.23 /

+0.67 (+0.39%)

JBLU JetBlue
$14.44 /

+0.065 (+0.45%)

HOOD Robinhood
$18.24 /

+1.145 (+6.70%)

GM General Motors
$58.71 /

+1.47 (+2.57%)

F Ford
$20.74 /

+0.165 (+0.80%)

ET Energy Transfer LP
$8.23 /

+0.075 (+0.92%)

DIDI Didi
$5.26 /

+0.32 (+6.48%)

CS Credit Suisse
$9.68 /

+0.04 (+0.41%)

CPNG Coupang
$29.86 /

+0.895 (+3.09%)

BYSI BeyondSpring
$4.46 /

+0.08 (+1.83%)

BIIB Biogen
$237.29 /

-21.07 (-8.16%)

BBBY Bed Bath & Beyond
$15.27 /

+0.36 (+2.41%)

On The Fly
Fly Intel: Pre-market Movers » 08:57
12/30/21
12/30
08:57
12/30/21
08:57
DNAY

Codex DNA

$9.36 /

+2.66 (+39.70%)

, HUGE

FSD Pharma

/

+

, MSTR

MicroStrategy

$557.42 /

-10.94 (-1.92%)

, BYSI

BeyondSpring

$4.38 /

-0.12 (-2.67%)

, DIDI

Didi

$4.94 /

-0.44 (-8.18%)

, VGR

Vector Group

$17.17 /

+0.105 (+0.62%)

, BIIB

Biogen

$258.29 /

+22.27 (+9.44%)

, MU

Micron

$96.16 /

+3.26 (+3.51%)

, DOUG

Douglas Elliman

/

+

Check out this morning's…

ShowHide Related Items >><<
VGR Vector Group
$17.17 /

+0.105 (+0.62%)

MU Micron
$96.16 /

+3.26 (+3.51%)

MSTR MicroStrategy
$557.42 /

-10.94 (-1.92%)

HUGE FSD Pharma
/

+

DNAY Codex DNA
$9.36 /

+2.66 (+39.70%)

DIDI Didi
$4.94 /

-0.44 (-8.18%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BIIB Biogen
$258.29 /

+22.27 (+9.44%)

DNAY Codex DNA
$9.36 /

+2.66 (+39.70%)

12/30/21 KeyBanc
Pfizer deal provides key validation of Codex DNA's technology, says KeyBanc
10/14/21 Cowen
Codex DNA coverage transferred at Cowen
07/13/21 Cowen
Cowen starts 'promising' Codex DNA at Outperform
07/13/21 Jefferies
Jefferies starts 'discounted' Codex DNA at Buy with $23 price target
HUGE FSD Pharma
/

+

MSTR MicroStrategy
$557.42 /

-10.94 (-1.92%)

10/29/21 Canaccord
MicroStrategy price target raised to $871 from $780 at Canaccord
08/24/21 Jefferies
MicroStrategy price target raised to $700 from $640 at Jefferies
08/20/21 Citi
Citi places Sell rating on MicroStrategy under review over bitcoin
07/30/21 Canaccord
MicroStrategy price target lowered to $780 from $920 at Canaccord
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
DIDI Didi
$4.94 /

-0.44 (-8.18%)

07/28/21 Alliance Global Partners
Alliance Global Partners bullish on Aurora Mobile despite regulatory changes
07/28/21 Alliance Global Partners
iClick Interactive price target lowered to $15 from $21 at Alliance Global
07/26/21 Atlantic Equities
Atlantic Equities downgrades DiDi to Neutral amid active investigations
07/26/21 Atlantic Equities
DiDi downgraded to Neutral from Overweight at Atlantic Equities
VGR Vector Group
$17.17 /

+0.105 (+0.62%)

11/15/21 Barclays
Vector Group upgraded to Equal Weight from Underweight at Barclays
11/09/21 Oppenheimer
Vector Group upgraded to Outperform from Perform at Oppenheimer
09/13/21 Barclays
Vector Group downgraded to Underweight from Equal Weight at Barclays
BIIB Biogen
$258.29 /

+22.27 (+9.44%)

12/30/21 Cantor Fitzgerald
Biogen takeout would be 'best-case exit strategy', says Cantor Fitzgerald
12/30/21 Baird
Biogen buyout rumor seems 'odd from multiple perspectives,' says Baird
12/30/21 Canaccord
Biogen takeout report may bring 'downside protection,' says Canaccord
12/30/21 Wells Fargo
Biogen price target raised to $284 from $250 at Wells Fargo
MU Micron
$96.16 /

+3.26 (+3.51%)

12/29/21 Benchmark
Benchmark says Western Digital getting boost from report of Samsung NAND trouble
12/29/21 Wells Fargo
Samsung NAND news positive for Western Digital and Micron, says Wells Fargo
12/21/21
Fly Intel: Top five analyst upgrades
12/21/21 Evercore ISI
February quarter 'clearly a trough' for Micron, says Evercore ISI
DOUG Douglas Elliman
/

+

VGR Vector Group
$17.17 /

+0.105 (+0.62%)

MU Micron
$96.16 /

+3.26 (+3.51%)

MSTR MicroStrategy
$557.42 /

-10.94 (-1.92%)

DNAY Codex DNA
$9.36 /

+2.66 (+39.70%)

DIDI Didi
$4.94 /

-0.44 (-8.18%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BIIB Biogen
$258.29 /

+22.27 (+9.44%)

  • 30
    Jun
  • 18
    Jun
MU Micron
$96.16 /

+3.26 (+3.51%)

DIDI Didi
$4.94 /

-0.44 (-8.18%)

BIIB Biogen
$258.29 /

+22.27 (+9.44%)

VGR Vector Group
$17.17 /

+0.105 (+0.62%)

MU Micron
$96.16 /

+3.26 (+3.51%)

MSTR MicroStrategy
$557.42 /

-10.94 (-1.92%)

HUGE FSD Pharma
/

+

DNAY Codex DNA
$9.36 /

+2.66 (+39.70%)

DIDI Didi
$4.94 /

-0.44 (-8.18%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BIIB Biogen
$258.29 /

+22.27 (+9.44%)

VGR Vector Group
$17.17 /

+0.105 (+0.62%)

MU Micron
$96.16 /

+3.26 (+3.51%)

MSTR MicroStrategy
$557.42 /

-10.94 (-1.92%)

HUGE FSD Pharma
/

+

DIDI Didi
$4.94 /

-0.44 (-8.18%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BIIB Biogen
$258.29 /

+22.27 (+9.44%)

Hot Stocks
BeyondSpring expects cash to support ongoing programs over the next year » 08:09
12/30/21
12/30
08:09
12/30/21
08:09
BYSI

BeyondSpring

$4.38 /

-0.12 (-2.67%)

As of September 30, 2021,…

As of September 30, 2021, the Company had cash, cash equivalents, and short-term investments of $91.6M. The Company believes it has sufficient cash to support its ongoing clinical programs over the next year, including its immuno-oncology pipeline.

ShowHide Related Items >><<
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

Hot Stocks
BeyondSpring announces upcoming clinical milestones » 08:09
12/30/21
12/30
08:09
12/30/21
08:09
BYSI

BeyondSpring

$4.38 /

-0.12 (-2.67%)

1H 2022: expected…

1H 2022: expected regulatory update for CIN indication in China; continuing discussions with FDA on regulatory pathway for CIN in the U.S. 2H 2022: NDA Submission for plinabulin in NSCLC. 2H 2022: Phase 2 data from the Big Ten Cancer Research Consortium, IIT study expected in plinabulin + nivolumab + ipilimumab in platinum and checkpoint inhibitor-resistant SCLC. 2H 2022: Preliminary Phase 1 data and plinabulin immune mechanism data from the MD Anderson Cancer Center, IIT study expected in plinabulin + PD-1/PD-L1 inhibitors + radiation in patients with seven cancer types.

ShowHide Related Items >><<
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

Earnings
BeyondSpring reports Q3 EPS (47c), consensus (37c) » 08:08
12/30/21
12/30
08:08
12/30/21
08:08
BYSI

BeyondSpring

$4.38 /

-0.12 (-2.67%)

Reports Q3 revenue…

Reports Q3 revenue $337,000, consensus $9.07M. "In the third quarter, we continued to move forward in developing plinabulin's potential as a 'pipeline in a drug' for patients in need. We are developing a wealth of clinical data showing plinabulin's dual benefit as an anti-cancer agent, shown with OS benefit in Dublin-3 study, with additional benefit in preventing CIN, which we believe will support the important role of plinabulin as a versatile cancer treatment option, and potentially, as a 'cornerstone' therapy in IO combinations," said Dr. Lan Huang, co-founder, chairwoman and chief executive officer of BeyondSpring. "We look forward to executing on our plans for the potential commercial launch of plinabulin in CIN, our first indication in China, where we are excited to work with a leading oncology company, Hengrui, in the commercialization and co-development of plinabulin. Our discussions will continue with the U.S. FDA regarding the potential regulatory pathway for CIN in the U.S. market. At the same time, we are very focused on preparing for our NDA filing for plinabulin in NSCLC. Based on discussions with regulatory agencies in the U.S. and in China, we now anticipate submitting our NDA in the 2H 2022. The year ahead will be very busy and significant for BYSI, and we remain dedicated to enabling plinabulin to achieve its full potential and to bringing added value to the treatment of cancer patients," concluded Dr. Huang.

ShowHide Related Items >><<
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

BYSI BeyondSpring
$4.38 /

-0.12 (-2.67%)

Over a month ago
Hot Stocks
BeyondSpring announces new data on plinabulin » 07:05
12/15/21
12/15
07:05
12/15/21
07:05
BYSI

BeyondSpring

$4.08 /

-0.12 (-2.86%)

BeyondSpring…

BeyondSpring Pharmaceuticals announced new data highlighting the mechanism of action of plinabulin in the prevention of chemotherapy-induced neutropenia, CIN, at the 63rd American Society of Hematology, ASH, Annual Meeting and Exposition. The data demonstrate that adding plinabulin to a myelosuppressive regimen rapidly reversed neutropenia and leukopenia in the PROTECTIVE-1 and -2 clinical studies by protecting progenitor stem cells in the bone marrow. "This clinical data provides evidence confirming the hypothesized progenitor stem cell protective mechanism of action for plinabulin, which further validates the positive Phase 3 data from the PROTECTIVE-2 clinical program. These data also build upon the rapid effect seen in clinical trials to date and support the opportunity for enhanced CIN prevention care with plinabulin," said Dr. Douglas Blayney, professor of medicine at Stanford University Medical School and global principal investigator for the CIN studies. "These data provide a strong rationale for combining plinabulin with pegfilgrastim, since the latter has a mechanism of action exerting CIN prevention in week 2 of the chemotherapy cycle while plinabulin shows a week 1 benefit. This early CIN benefit is critically important because these white blood cells are the body's main source of defense against infection. If a cancer patient gets an infection due to CIN, it may affect their ability to finish chemotherapy for cancer treatment." Poster Title: "Plinabulin Rapidly Reverses Myelosuppression Induced by Chemotherapy." Key Findings: This new data analysis from the PROTECTIVE-1 and 2 studies aimed to further evaluate plinabulin's fast onset mechanism of action and potential progenitor stem cell involvement in plinabulin's fast onset MoA. The comparison was made between cancer patients receiving plinabulin 40 mg or not receiving plinabulin, and with all patients receiving myelosuppressive chemotherapy. Plinabulin rapidly reversed chemo-induced myelosuppression in both the PROTECTIVE-1 and 2 human studies.

ShowHide Related Items >><<
BYSI BeyondSpring
$4.08 /

-0.12 (-2.86%)

BYSI BeyondSpring
$4.08 /

-0.12 (-2.86%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.08 /

-0.12 (-2.86%)

BYSI BeyondSpring
$4.08 /

-0.12 (-2.86%)

BYSI BeyondSpring
$4.08 /

-0.12 (-2.86%)

Hot Stocks
BeyondSpring announces analysis of data from Phase 3 PROTECTIVE-2 trial » 08:09
12/10/21
12/10
08:09
12/10/21
08:09
BYSI

BeyondSpring

$4.50 /

-0.35 (-7.22%)

BeyondSpring…

BeyondSpring Pharmaceuticals announced the presentation of additional analyses from the Phase 3 portion of the PROTECTIVE-2 trial evaluating the combination of plinabulin and pegfilgrastim for the prevention of chemotherapy-induced neutropenia, CIN, in breast cancer patients at the 2021 San Antonio Breast Cancer Symposium, SABCS, held both live and virtually from December 7-10, 2021. Poster Title: Mechanistic evidence associated with the benefit of plinabulin significantly reducing bone pain in breast cancer patients treated with TAC and pegfilgrastim. Key Findings: Patients treated with pegfilgrastim and plinabulin experienced less bone pain than did patients treated with pegfilgrastim only; Treatment with plinabulin may mitigate the need for compensatory hematopoiesis and intracavitary pressure build-up, resulting in bone pain sensations; Patients treated with pegfilgrastim and plinabulin had a higher absolute neutrophil count at the nadir; The depth of ANC nadir was statistically significantly correlated with bone pain scores. Poster Title: Combination plinabulin+pegfilgrastim had better toxicity management and health related quality-of-life compared to Peg alone in early-stage breast cancer patients treated with taxotere, doxorubicin and cyclophosphamide. Key Findings: Adding plinabulin to pegfilgrastim decreases toxicity and improves HrQoL among patients with breast cancer receiving TAC; The adverse event profile among patients treated with plinabulin and pegfilgrastim was shifted towards lower grade AEs; Adding plinabulin to pegfilgrastim prevented a decline in HrQoL scores for mobility, self-care, daily activities, pain and anxiety.

ShowHide Related Items >><<
BYSI BeyondSpring
$4.50 /

-0.35 (-7.22%)

BYSI BeyondSpring
$4.50 /

-0.35 (-7.22%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
BYSI BeyondSpring
$4.50 /

-0.35 (-7.22%)

BYSI BeyondSpring
$4.50 /

-0.35 (-7.22%)

BYSI BeyondSpring
$4.50 /

-0.35 (-7.22%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.